Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars in Europe, follows-on-biologics in US and subsequent entry biological in japan. Due to their high degree of similarity with the biological reference product, they have no clinically evidenced and meaningful differences from the reference product in terms of quality, safety or efficacy. Biogenerics drugs provide effective treatment for number of serious and life-threatening illness because of their high specificity and activity. Biogeneric are more complex compared to small molecule drugs. Their quality and safety are highly dependent on the process of production (choice of cell type, development of the genetically modified cell for production, etc.), purification and formulation. The constitution of the biogeneric drugs can be either small molecules such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Biogeneric drugs are increasing gaining prominence given the loss of exclusivity of big branded drugs. In Europe, biogenerics can be marketed through independent applicant following expiry of patent and market exclusivity periods of the reference product. Regulatory harmonization, naming and labelling, innovative licensure norms and route to market for the biogeneric drugs are issues expected to gain attention and traction from big drug makers in the forthcoming years.
This report aims to provide a comprehensive presentation of the global market for Biogeneric Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biogeneric Drugs. This report contains market size and forecasts of Biogeneric Drugs in global, including the following market information:
Global Biogeneric Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biogeneric Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biogeneric Drugs companies in 2022 (%)
The global Biogeneric Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biogeneric drugs market is expected to increase in forecast period due to increased treatment options, value added services to care patient and healthcare community. Due to drugs introduces competition, increasing affordability of biologics which delivers saving for healthcare systems are the same factors which increase biogeneric drugs market. Introduction of affordable, high-quality biogenerics drugs improves access to life changing medicine for patients worldwide. Opportunities for generic drug products is huge but there are regulations that must be adhered to when strategizing the best ways to maximize a company?s return. Government regulation may be adhere the growth of drug development investment or planning an entry into a market with a new biogeneric products.
We surveyed the Biogeneric Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biogeneric Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biogeneric Drugs Market Segment Percentages, by Type, 2022 (%)
Insulins
Growth Hormones
Monoclonal Antibodies
Others
Global Biogeneric Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biogeneric Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Research Centers
Global Biogeneric Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biogeneric Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biogeneric Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biogeneric Drugs revenues share in global market, 2022 (%)
Key companies Biogeneric Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biogeneric Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz International
Teva pharmaceutical industries
Mylan
3SBio
Shanghai Fosun Pharmaceutical
Tonghua Dongbao Pharmaceutical
Biocon
Reliance life sciences
Probiomed
Biosidus
AMEGA Biotech
Celltrion
LG life Science
Dong-A Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biogeneric Drugs, market overview.
Chapter 2: Global Biogeneric Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Biogeneric Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biogeneric Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biogeneric Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biogeneric Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biogeneric Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biogeneric Drugs Overall Market Size
2.1 Global Biogeneric Drugs Market Size: 2022 VS 2029
2.2 Global Biogeneric Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biogeneric Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Biogeneric Drugs Players in Global Market
3.2 Top Global Biogeneric Drugs Companies Ranked by Revenue
3.3 Global Biogeneric Drugs Revenue by Companies
3.4 Global Biogeneric Drugs Sales by Companies
3.5 Global Biogeneric Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biogeneric Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biogeneric Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biogeneric Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biogeneric Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biogeneric Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biogeneric Drugs Market Size Markets, 2022 & 2029
4.1.2 Insulins
4.1.3 Growth Hormones
4.1.4 Monoclonal Antibodies
4.1.5 Others
4.2 By Type - Global Biogeneric Drugs Revenue & Forecasts
4.2.1 By Type - Global Biogeneric Drugs Revenue, 2018-2023
4.2.2 By Type - Global Biogeneric Drugs Revenue, 2024-2029
4.2.3 By Type - Global Biogeneric Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Biogeneric Drugs Sales & Forecasts
4.3.1 By Type - Global Biogeneric Drugs Sales, 2018-2023
4.3.2 By Type - Global Biogeneric Drugs Sales, 2024-2029
4.3.3 By Type - Global Biogeneric Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Biogeneric Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biogeneric Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Research Centers
5.2 By Application - Global Biogeneric Drugs Revenue & Forecasts
5.2.1 By Application - Global Biogeneric Drugs Revenue, 2018-2023
5.2.2 By Application - Global Biogeneric Drugs Revenue, 2024-2029
5.2.3 By Application - Global Biogeneric Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Biogeneric Drugs Sales & Forecasts
5.3.1 By Application - Global Biogeneric Drugs Sales, 2018-2023
5.3.2 By Application - Global Biogeneric Drugs Sales, 2024-2029
5.3.3 By Application - Global Biogeneric Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Biogeneric Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biogeneric Drugs Market Size, 2022 & 2029
6.2 By Region - Global Biogeneric Drugs Revenue & Forecasts
6.2.1 By Region - Global Biogeneric Drugs Revenue, 2018-2023
6.2.2 By Region - Global Biogeneric Drugs Revenue, 2024-2029
6.2.3 By Region - Global Biogeneric Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Biogeneric Drugs Sales & Forecasts
6.3.1 By Region - Global Biogeneric Drugs Sales, 2018-2023
6.3.2 By Region - Global Biogeneric Drugs Sales, 2024-2029
6.3.3 By Region - Global Biogeneric Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biogeneric Drugs Revenue, 2018-2029
6.4.2 By Country - North America Biogeneric Drugs Sales, 2018-2029
6.4.3 US Biogeneric Drugs Market Size, 2018-2029
6.4.4 Canada Biogeneric Drugs Market Size, 2018-2029
6.4.5 Mexico Biogeneric Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biogeneric Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Biogeneric Drugs Sales, 2018-2029
6.5.3 Germany Biogeneric Drugs Market Size, 2018-2029
6.5.4 France Biogeneric Drugs Market Size, 2018-2029
6.5.5 U.K. Biogeneric Drugs Market Size, 2018-2029
6.5.6 Italy Biogeneric Drugs Market Size, 2018-2029
6.5.7 Russia Biogeneric Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Biogeneric Drugs Market Size, 2018-2029
6.5.9 Benelux Biogeneric Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biogeneric Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Biogeneric Drugs Sales, 2018-2029
6.6.3 China Biogeneric Drugs Market Size, 2018-2029
6.6.4 Japan Biogeneric Drugs Market Size, 2018-2029
6.6.5 South Korea Biogeneric Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Biogeneric Drugs Market Size, 2018-2029
6.6.7 India Biogeneric Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biogeneric Drugs Revenue, 2018-2029
6.7.2 By Country - South America Biogeneric Drugs Sales, 2018-2029
6.7.3 Brazil Biogeneric Drugs Market Size, 2018-2029
6.7.4 Argentina Biogeneric Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biogeneric Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biogeneric Drugs Sales, 2018-2029
6.8.3 Turkey Biogeneric Drugs Market Size, 2018-2029
6.8.4 Israel Biogeneric Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Biogeneric Drugs Market Size, 2018-2029
6.8.6 UAE Biogeneric Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sandoz International
7.1.1 Sandoz International Company Summary
7.1.2 Sandoz International Business Overview
7.1.3 Sandoz International Biogeneric Drugs Major Product Offerings
7.1.4 Sandoz International Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Sandoz International Key News & Latest Developments
7.2 Teva pharmaceutical industries
7.2.1 Teva pharmaceutical industries Company Summary
7.2.2 Teva pharmaceutical industries Business Overview
7.2.3 Teva pharmaceutical industries Biogeneric Drugs Major Product Offerings
7.2.4 Teva pharmaceutical industries Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Teva pharmaceutical industries Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Biogeneric Drugs Major Product Offerings
7.3.4 Mylan Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 3SBio
7.4.1 3SBio Company Summary
7.4.2 3SBio Business Overview
7.4.3 3SBio Biogeneric Drugs Major Product Offerings
7.4.4 3SBio Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.4.5 3SBio Key News & Latest Developments
7.5 Shanghai Fosun Pharmaceutical
7.5.1 Shanghai Fosun Pharmaceutical Company Summary
7.5.2 Shanghai Fosun Pharmaceutical Business Overview
7.5.3 Shanghai Fosun Pharmaceutical Biogeneric Drugs Major Product Offerings
7.5.4 Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Shanghai Fosun Pharmaceutical Key News & Latest Developments
7.6 Tonghua Dongbao Pharmaceutical
7.6.1 Tonghua Dongbao Pharmaceutical Company Summary
7.6.2 Tonghua Dongbao Pharmaceutical Business Overview
7.6.3 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Major Product Offerings
7.6.4 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Tonghua Dongbao Pharmaceutical Key News & Latest Developments
7.7 Biocon
7.7.1 Biocon Company Summary
7.7.2 Biocon Business Overview
7.7.3 Biocon Biogeneric Drugs Major Product Offerings
7.7.4 Biocon Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Biocon Key News & Latest Developments
7.8 Reliance life sciences
7.8.1 Reliance life sciences Company Summary
7.8.2 Reliance life sciences Business Overview
7.8.3 Reliance life sciences Biogeneric Drugs Major Product Offerings
7.8.4 Reliance life sciences Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Reliance life sciences Key News & Latest Developments
7.9 Probiomed
7.9.1 Probiomed Company Summary
7.9.2 Probiomed Business Overview
7.9.3 Probiomed Biogeneric Drugs Major Product Offerings
7.9.4 Probiomed Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Probiomed Key News & Latest Developments
7.10 Biosidus
7.10.1 Biosidus Company Summary
7.10.2 Biosidus Business Overview
7.10.3 Biosidus Biogeneric Drugs Major Product Offerings
7.10.4 Biosidus Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Biosidus Key News & Latest Developments
7.11 AMEGA Biotech
7.11.1 AMEGA Biotech Company Summary
7.11.2 AMEGA Biotech Biogeneric Drugs Business Overview
7.11.3 AMEGA Biotech Biogeneric Drugs Major Product Offerings
7.11.4 AMEGA Biotech Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.11.5 AMEGA Biotech Key News & Latest Developments
7.12 Celltrion
7.12.1 Celltrion Company Summary
7.12.2 Celltrion Biogeneric Drugs Business Overview
7.12.3 Celltrion Biogeneric Drugs Major Product Offerings
7.12.4 Celltrion Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Celltrion Key News & Latest Developments
7.13 LG life Science
7.13.1 LG life Science Company Summary
7.13.2 LG life Science Biogeneric Drugs Business Overview
7.13.3 LG life Science Biogeneric Drugs Major Product Offerings
7.13.4 LG life Science Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.13.5 LG life Science Key News & Latest Developments
7.14 Dong-A Pharmaceutical
7.14.1 Dong-A Pharmaceutical Company Summary
7.14.2 Dong-A Pharmaceutical Business Overview
7.14.3 Dong-A Pharmaceutical Biogeneric Drugs Major Product Offerings
7.14.4 Dong-A Pharmaceutical Biogeneric Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Dong-A Pharmaceutical Key News & Latest Developments
8 Global Biogeneric Drugs Production Capacity, Analysis
8.1 Global Biogeneric Drugs Production Capacity, 2018-2029
8.2 Biogeneric Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biogeneric Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biogeneric Drugs Supply Chain Analysis
10.1 Biogeneric Drugs Industry Value Chain
10.2 Biogeneric Drugs Upstream Market
10.3 Biogeneric Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biogeneric Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biogeneric Drugs in Global Market
Table 2. Top Biogeneric Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biogeneric Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biogeneric Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Biogeneric Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Biogeneric Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biogeneric Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Biogeneric Drugs Product Type
Table 9. List of Global Tier 1 Biogeneric Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biogeneric Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biogeneric Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biogeneric Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biogeneric Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biogeneric Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Biogeneric Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Biogeneric Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biogeneric Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biogeneric Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biogeneric Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Biogeneric Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Biogeneric Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biogeneric Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biogeneric Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biogeneric Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Biogeneric Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Biogeneric Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biogeneric Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biogeneric Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Biogeneric Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biogeneric Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biogeneric Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biogeneric Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biogeneric Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biogeneric Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biogeneric Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biogeneric Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biogeneric Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Biogeneric Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biogeneric Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biogeneric Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Biogeneric Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biogeneric Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biogeneric Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biogeneric Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biogeneric Drugs Sales, (K Units), 2024-2029
Table 46. Sandoz International Company Summary
Table 47. Sandoz International Biogeneric Drugs Product Offerings
Table 48. Sandoz International Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sandoz International Key News & Latest Developments
Table 50. Teva pharmaceutical industries Company Summary
Table 51. Teva pharmaceutical industries Biogeneric Drugs Product Offerings
Table 52. Teva pharmaceutical industries Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Teva pharmaceutical industries Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Biogeneric Drugs Product Offerings
Table 56. Mylan Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. 3SBio Company Summary
Table 59. 3SBio Biogeneric Drugs Product Offerings
Table 60. 3SBio Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. 3SBio Key News & Latest Developments
Table 62. Shanghai Fosun Pharmaceutical Company Summary
Table 63. Shanghai Fosun Pharmaceutical Biogeneric Drugs Product Offerings
Table 64. Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Shanghai Fosun Pharmaceutical Key News & Latest Developments
Table 66. Tonghua Dongbao Pharmaceutical Company Summary
Table 67. Tonghua Dongbao Pharmaceutical Biogeneric Drugs Product Offerings
Table 68. Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Tonghua Dongbao Pharmaceutical Key News & Latest Developments
Table 70. Biocon Company Summary
Table 71. Biocon Biogeneric Drugs Product Offerings
Table 72. Biocon Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Biocon Key News & Latest Developments
Table 74. Reliance life sciences Company Summary
Table 75. Reliance life sciences Biogeneric Drugs Product Offerings
Table 76. Reliance life sciences Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Reliance life sciences Key News & Latest Developments
Table 78. Probiomed Company Summary
Table 79. Probiomed Biogeneric Drugs Product Offerings
Table 80. Probiomed Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Probiomed Key News & Latest Developments
Table 82. Biosidus Company Summary
Table 83. Biosidus Biogeneric Drugs Product Offerings
Table 84. Biosidus Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Biosidus Key News & Latest Developments
Table 86. AMEGA Biotech Company Summary
Table 87. AMEGA Biotech Biogeneric Drugs Product Offerings
Table 88. AMEGA Biotech Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AMEGA Biotech Key News & Latest Developments
Table 90. Celltrion Company Summary
Table 91. Celltrion Biogeneric Drugs Product Offerings
Table 92. Celltrion Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Celltrion Key News & Latest Developments
Table 94. LG life Science Company Summary
Table 95. LG life Science Biogeneric Drugs Product Offerings
Table 96. LG life Science Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. LG life Science Key News & Latest Developments
Table 98. Dong-A Pharmaceutical Company Summary
Table 99. Dong-A Pharmaceutical Biogeneric Drugs Product Offerings
Table 100. Dong-A Pharmaceutical Biogeneric Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Dong-A Pharmaceutical Key News & Latest Developments
Table 102. Biogeneric Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Biogeneric Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Biogeneric Drugs Production by Region, 2018-2023 (K Units)
Table 105. Global Biogeneric Drugs Production by Region, 2024-2029 (K Units)
Table 106. Biogeneric Drugs Market Opportunities & Trends in Global Market
Table 107. Biogeneric Drugs Market Drivers in Global Market
Table 108. Biogeneric Drugs Market Restraints in Global Market
Table 109. Biogeneric Drugs Raw Materials
Table 110. Biogeneric Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Biogeneric Drugs Downstream
Table 112. Biogeneric Drugs Downstream Clients in Global Market
Table 113. Biogeneric Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biogeneric Drugs Segment by Type in 2022
Figure 2. Biogeneric Drugs Segment by Application in 2022
Figure 3. Global Biogeneric Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biogeneric Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biogeneric Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Biogeneric Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biogeneric Drugs Revenue in 2022
Figure 9. By Type - Global Biogeneric Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biogeneric Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Biogeneric Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Biogeneric Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biogeneric Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Biogeneric Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Biogeneric Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biogeneric Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biogeneric Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biogeneric Drugs Sales Market Share, 2018-2029
Figure 23. US Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biogeneric Drugs Sales Market Share, 2018-2029
Figure 28. Germany Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biogeneric Drugs Sales Market Share, 2018-2029
Figure 37. China Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biogeneric Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biogeneric Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biogeneric Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biogeneric Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biogeneric Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biogeneric Drugs by Region, 2022 VS 2029
Figure 54. Biogeneric Drugs Industry Value Chain
Figure 55. Marketing Channels
